Hannah Linden, M.D., is a board certified oncologist at the Hematology/Oncology Clinic at Harborview and SCCA and a UW professor of Medicine and Oncology.
Dr. Linden is active in research including estrogen receptor targeted therapies. She enjoys the opportunity to learn more about the science of breast cancer and how to integrate advances in science into patient care. She also enjoys getting to know patients and helping them make treatment choices which fit with their goals and beliefs.
Dr. Linden earned her M.D. at the University of Massachusetts. Her clinical and research interests include endocrine treatment of breast cancer, investigational breast cancer clinical treatments, molecular imaging and improving care of vulnerable populations.